ArticleFrontiers in immunology2026

Clinical impact of first-line chemotherapy combined with immune checkpoint inhibitors for limited-stage small cell lung cancer patients: a real-world propensity score matching study.

Quanman Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.